S. Murchan
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 3
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 10
- Microbiology top 10%
- Bacterial Infections and Vaccines 4
-
- Pneumonia and Respiratory Infections 8
- Respiratory viral infections research 3
-
- Streptococcal Infections and Treatments 5
- Co-authors
- Robert CunneyHazel M. AuckenG. L. O’NeillD O’FlanaganKaren BurnsAlberto Gil-SetasMary MeehanKirsten Schaffer
- Journals
- Eurosurveillance (3 papers)Epidemiology and Infection (2 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- IrelandNorwayUnited Kingdom
In The Last Decade
S. Murchan
20 papers receiving 535 citations
Peers
Comparison fields: 5 of 65
- Clinical Biochemistry 202
- Applied Microbiology and Biotechnology 47
- Molecular Medicine 105
- Infectious Diseases 365
- Microbiology 59
Countries citing papers authored by S. Murchan
This map shows the geographic impact of S. Murchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Murchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Murchan more than expected).
Fields of papers citing papers by S. Murchan
This network shows the impact of papers produced by S. Murchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Murchan. The network helps show where S. Murchan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Murchan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 13 | |
| 2 | 2021 | 32 | |
| 3 | 2019 | 13 | |
| 4 | Is It Time To Review The Vaccination Strategy To Protect Adults Against Invasive Pneumococcal Disease? | 2019 | 4 |
| 5 | 2018 | 186 | |
| 6 | 2018 | 29 | |
| 7 | 2017 | 35 | |
| 8 | 2016 | 15 | |
| 9 | 2013 | 36 | |
| 10 | 2012 | 3 | |
| 11 | 2011 | 26 | |
| 12 | 2010 | 9 | |
| 13 | 2006 | 19 | |
| 14 | 2006 | 4 | |
| 15 | 2006 | 2 | |
| 16 | 2005 | 7 | |
| 17 | 2004 | 10 | |
| 18 | 2004 | 43 | |
| 19 | 2001 | 56 | |
| 20 | 1998 | 9 |
About S. Murchan
S. Murchan is a scholar working on Applied Microbiology and Biotechnology, Microbiology, Molecular Medicine, Infectious Diseases and Clinical Biochemistry, having authored 20 papers that have together received 551 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (10 papers), Pneumonia and Respiratory Infections (8 papers), Streptococcal Infections and Treatments (5 papers), Antibiotic Use and Resistance (5 papers), Bacterial Infections and Vaccines (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Respiratory viral infections research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Clinical Biochemistry (202 citations), Applied Microbiology and Biotechnology (47 citations), Molecular Medicine (105 citations), Infectious Diseases (365 citations) and Microbiology (59 citations). S. Murchan has collaborated with scholars based in Ireland, Norway and United Kingdom. Frequent co-authors include Robert Cunney, Hazel M. Aucken, G. L. O’Neill, D O’Flanagan, Karen Burns, Alberto Gil-Setas, Mary Meehan, Kirsten Schaffer, Teresa M. Coque and Luı́sa Peixe. Their work appears in journals such as Eurosurveillance, Epidemiology and Infection, Clinical Microbiology and Infection, Journal of Hospital Infection and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.